focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

30 Sep 2014 07:00

RNS Number : 9050S
Fitbug Holdings PLC
30 September 2014
 



30 September 2014

Fitbug Holdings Plc ('Fitbug' or 'the Company')

Interim results and Launch of KiQplan Digital Coaching Product

 

Fitbug Holdings Plc, the AIM listed provider of online personal health and well-being services, announces its results for the six months ended 30 June 2014.

 

Overview

 

· Sales increased by 98% to £914,000 (H1 2013: £461,000) reflecting increased device sales following launch of Fitbug Orb

· Launch of KiQplan™ digital coaching product on track for November

· February 2015 trial date set for legal action against Fitbit

· Pre-tax loss of £1,610,000 (H1 2013: loss of £1,049,000) reflecting increased investment in KiQplan™ development and legal fees to support the Fitbit action

· New loan of £600,000 secured on attractive terms

 

Malcolm Fried, CEO, said: "The November launch of KiQplan™, together with the support of NW1 Investments Limited and the Kirsh Group, leaves the business well placed to continue developing its products and trading relationships and to pursue the legal action against Fitbit to fruition."

 

Chairman and CEO's Statement

 

This has been an active period for Fitbug. Sales growth during the period reflected increasing interest in wearables. In recent months, Fitbug has manufactured and shipped a significant volume of devices and KiQplan™ products to our US distributors ahead of the Thanksgiving/Christmas sale period.

 

KiQplan™ provides a range of personalized, digital health coaching services designed to work with a range of activity trackers to help participants meet specific health, weight and fitness goals. These digital products will also sync with the inbuilt tracker chips within the latest generation of mobile smart phones and smart watches, as well as leading compatible apps. The first four KiQplans will be launched in the US retail market in November 2014.

 

In anticipation of the release of our new KiQplan product in the US retail market, Fitbug has agreed further loan funding of £600,000. The loan is repayable by 31 July 2015 and will accrue interest at a favourable rate of 5% per annum, payable on a quarterly basis. The funds will be loaned by The Kirsh Group through NW1 Investments Limited, a company in which the family of David Turner and Allan Fisher have a material interest. The independent directors of the Company, being Fergus Kee, Malcolm Fried, Paul Landau, Ann Jones, Andrew Brummer and Geoffrey Simmonds, consider that, having consulted with Cantor Fitzgerald Europe, the terms of the loan are fair and reasonable in so far as the shareholders are concerned.

 

The results for the six months to 30 June show a pre-tax loss of £1,610,000 (H1 2013: loss of £1,049,000) reflecting increased investment in development of KiQplan™ together with legal and professional fees to support the legal action against Fitbit. Cash at 30 June 2014 was £160,000 (30 June 2013: £284,000).

 

A trial date of 9 February 2015 has been set by the U.S. District Court of Northern California to hear the Company's legal action against Fitbit. This legal action alleges trademark infringement, unfair competition and unfair business practices. The Company has asked the court to order Fitbit to permanently cease use of its Fitbit mark and from engaging in conduct that is causing confusion with Fitbug's brand and services. The Company believes that it has a strong case.

 

Fergus Kee, Chairman, Fitbug Holdings Plc

Malcolm Fried, CEO, Fitbug Holdings Plc

 

 

For further information visit www.fitbugholdings.com or contact:

 

Malcolm Fried/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce

Hybridan LLP

020 3 713 4581

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

Consolidated statement of comprehensive income

for the period ended 30 June 2014

 

Unaudited 6 months

Unaudited 6 months

Audited

Year

ended

ended

Ended

30 June

30 June

31 December

2014

2013

2013

Note

£'000

£'000

£'000

Continuing operations

Revenue

914

461

749

Cost of sales - normal

(578)

(281)

(371)

------------

------------

------------

Gross profit before exceptional items

336

180

378

Exceptional write down of obsolete inventory

-

-

(250)

------------

------------

------------

336

180

128

Operating and administrative expenses

(1,804)

(1,169)

(2,672)

Finance income

-

3

3

Finance costs

(142)

(63)

(152)

------------

------------

------------

Loss for the period before tax

(1,610)

(1,049)

(2,693)

Income tax

-

-

50

------------

------------

------------

Loss for the period and total comprehensive income for the period attributable to equity holders of the parent

(1,610)

(1,049)

(2,643)

------------

------------

------------

Loss per share

2

(1.0)

(0.6)

(1.6)

------------

------------

------------

Consolidated statement of changes in equity

for the six months ended 30 June 2014

 

 

Share

Share

Retained

Total

capital

Premium

deficit

Equity

£'000

£'000

£'000

£'000

Balance at 1 January 2013 (audited)

1,685

1034

(3,583)

(864)

Loss and total comprehensive income for the period

-

-

(1,049)

(1,049)

Share based payment

-

-

33

33

------------

------------

------------

------------

Balance at 30 June 2013 (unaudited)

1,685

1,034

(4,599)

(1,880)

Loss and total comprehensive income for the period

-

-

(1,594)

(1,594

Share based payment

-

-

34

34

------------

------------

------------

------------

Balance at 31 December 2013 (audited)

1,685

1,034

(6,159)

(3,440)

Loss and total comprehensive income for the period

-

-

(1,610)

(1,610)

Share based payment

-

-

33

33

------------

------------

------------

------------

Balance at 30 June 2014 (unaudited)

1,685

1,034

(7,736)

(5,017)

------------

------------

------------

------------

 

 

Consolidated Balance Sheet at 30 June 2014

 

Unaudited

Unaudited

Audited

6 months

6 months

Year

Ended

Ended

Ended

30 June

30 June

31 December

2014

2013

2013

£'000

£'000

£'000

Assets

Non-current assets

Intangible assets

285

117

120

Property, plant and equipment

17

16

14

------------

------------

------------

Total non-current assets

302

133

134

------------

------------

------------

Current assets

Inventories

1,063

422

723

Trade and other receivables

398

476

313

Cash and cash equivalents

160

284

139

------------

------------

------------

Total current assets

1,621

1,182

1,175

------------

------------

------------

Total assets

1,923

1,315

1,309

------------

------------

------------

Liabilities

Non-current liabilities

Borrowings

6,089

2,584

1,804

------------

------------

------------

Total non-current liabilities

6,089

2,584

1,804

------------

------------

------------

Current liabilities

Trade and other payables

776

499

567

Borrowings

75

112

2,378

------------

------------

------------

Total current liabilities

851

611

2,945

------------

------------

------------

Total liabilities

6,940

3,195

4,749

------------

------------

------------

Net liabilities

(5,017)

(1,880)

(3,440)

------------

------------

------------

Capital and reserves

Share capital

1,685

1,685

1,685

Share premium

1,034

1,034

1,034

Retained deficit

(7,736)

(4,599)

(6,159)

------------

------------

------------

Total equity

(5,017)

(1,880)

(3,440)

------------

------------

------------

 

Consolidated cash flow statement

for the six months ended 30 June 2014

 

Six months

Six months

12 Months

Ended

Ended

ended

30 June

30 June

31 December

2014

2013

2013

£'000

£'000

£'000

Cash flows from operating activities

Loss before taxation

(1,610)

(1,049)

(2,693)

Adjustments for:

- Depreciation and amortisation

6

6

37

- Share-based payments

33

33

67

- Finance income

-

(3)

(3)

- Finance expense

143

63

152

------------

------------

------------

Cash flows from operating activities before changes in working capital and provisions

(1,428)

(950)

(2,440)

- Increase in inventories

(340)

(28)

(329)

- Increase in trade and other receivables

(85)

(228)

(40)

- Increase/(decrease) in trade and other payables

209

166

259

------------

------------

------------

Net cash used in operations

(1,644)

(1,040)

(2,550)

------------

------------

------------

Cash flow from investing activities

Purchase of property, plant and equipment

(9)

(5)

(10)

Development costs capitalised

(165)

-

(27)

Finance income

-

-

3

------------

------------

------------

Net cash used in investing activities

(174)

(5)

(34)

------------

------------

------------

Cash flow from financing activities

Loan advances

2,000

750

2,250

Loan repayments

(18)

(9)

(23)

Finance expense

(143)

(60)

(152)

------------

------------

------------

Net cash generated from financing activities

1,839

681

2,075

------------

------------

------------

Net increase /(decrease) in cash and cash equivalents

21

(364)

(509)

Cash and cash equivalents at beginning of period

139

648

648

------------

------------

------------

Cash and cash equivalents at end of period

160

284

139

------------

------------

------------

 

Unaudited notes forming part of the consolidated interim financial statements

for the six months ended 30 June 2013

 

1 BASIS OF PREPARATION

 

Fitbug Holdings plc is a company incorporated in the United Kingdom under the Companies Act 2006. Its registered office address is 1st Floor Waterside House, 47-49 Kentish Town Road, London NW1 8NX.

 

The condensed consolidated interim financial statements of the company for the six months ended 30 June 2014 comprise the company and its subsidiaries (together referred to as "the group"). These interim statements do not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The interim financial information has been prepared using the same accounting policies, presentation, method of computation and estimation techniques as are expected to be adopted in the group financial statements for the year ending 31 December 2014 and which were adopted in the audited group financial statements for the year ended 31 December 2013.

 

The financial information for the year ended 31 December 2013 has been extracted from the statutory accounts for that period. The auditors have reported on the statutory accounts for the year ended 31 December 2013 and their report was unqualified. The auditors' report drew attention by emphasis of matter to issues surrounding the ability of the company to continue as going concern. A copy of those financial statements has been filed with the Registrar of Companies.

 

The condensed consolidated interim financial statements have been prepared using accounting policies consistent with International Financial Reporting Standards (IFRSs) as adopted in the EU. While the financial figures included in this half yearly report have been computed in accordance with IFRSs as adopted in the EU applicable to interim periods, this half yearly report does not contain sufficient information to constitute an interim financial report as that term is defined in IAS 34.

 

2 LOSS PER SHARE

 

The loss per share is based on a loss for the period attributable to equity holders of the Parent Company of £1,610,000 (2013 - loss of £1,049,000) and the weighted average number of ordinary shares being in issue for the period of 168,514,973 (2013 - 168,514,973).

 

The exercise of the outstanding options would reduce the loss per share and hence have an anti-dilutive effect. There are 13,000,000 (2013: 13,000,000) shares that could potentially be issued under the terms of options and a further 66,666,667 shares that could be potentially issued under the terms of the convertible loan that will potentially reduce future earnings per share.

 

3 GOING CONCERN

The condensed interim financial statements for the six months ended 30 June 2014 have been prepared on the assumption that the group will be able to continue trading as a going concern for the foreseeable future. At 30 June 2014 the group had net liabilities of £5,017,000, which includes loans of £1,500,000 from Kifin Limited, a Kirsh Group subsidiary, including a £1,000,000 loan issued under a convertible loan note instrument dated 28 June 2013. The other loan is repayable by 31 July 2015 and accrues interest at a rate of 5% per annum, payable on a quarterly basis.

 

The group also has loans of £4,589,000 from NW1 Investments Limited, a company connected to two of the directors of the Group.

 

Post period end, Fitbug Holdings plc agreed two separate loans totalling £2,350,000 loan from NW1 Investments Limited which are repayable by 31 July 2015 and will accrue interest at a rate of 5% per annum, payable on a quarterly basis.

 

The directors have prepared financial forecasts which suggest that, based on anticipated sales pipeline, the Group has sufficient facilities to meet its working and development capital requirements.

 

The directors have continued to adopt the going concern concept in preparing these interim financial statements on the basis that they believe that the anticipated sales pipeline and a number of opportunities currently available to them will generate improved revenue and profitability. The sales forecasts are however based on the achievement of and timings of revenue forecasts which, although believed reasonable by the directors are nevertheless, in part, outside the Group's direct control. If significant delays were to take place, these may render the Group's cash resources insufficient.

 

If as a result the Group were unable to continue as a going concern, then adjustments would be necessary to write assets down to their recoverable amounts, non-current assets and liabilities would be reclassified as current assets and liabilities and provisions would be required for any costs associated with closure.

 

Notes to Editors

 

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes, fitness operators and consumers. Increasingly, Fitbug's platform acts as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. An important part of the Company's focus is on building strategic partnerships with organisations which can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in the UK, Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFESALIAFIS
Date   Source Headline
27th Jul 20165:35 pmRNSHolding(s) in Company
25th Jul 20168:45 amRNSShare Option Schemes & Grant of Options
22nd Jul 20164:05 pmRNSResult of AGM & Result of General Meeting
21st Jul 20162:30 pmRNSFunding Update & Directors Participation
20th Jul 20165:15 pmRNSConditional Result of Open Offer
29th Jun 20169:45 amRNSNotice of 2016 Annual General Meeting and Posting
29th Jun 20167:01 amRNSProposed Fundraising and Loan Capitalisation
29th Jun 20167:00 amRNSBoard Changes
13th Jun 20167:10 amRNSFurther Working Capital Loan
13th Jun 20167:00 amRNSPreliminary Announcement of Results for 2015
8th Jun 20164:17 pmRNSHolding(s) in Company
22nd Mar 20167:00 amRNSSuccessful Customer Rollout With Strategic Partner
8th Feb 20167:00 amRNSLitigation Settlement
11th Jan 20167:00 amRNSAppointment of Non-Executive Director
30th Dec 20152:00 pmRNSTrading Update
23rd Dec 20151:00 pmRNSWorking Capital Raise
11th Dec 20154:15 pmRNSHolding(s) in Company
1st Dec 20157:00 amRNSBoard and Management Changes
23rd Nov 20157:00 amRNSLaunches Kiqplan Health & Fitness Training App
29th Oct 20157:00 amRNSHolding(s) in Company
19th Oct 20159:01 amRNSBoard Changes
30th Sep 20159:35 amRNSInterim Results
4th Sep 20152:30 pmRNSBoard Changes
27th Aug 20157:01 amRNSAppointment of CEO
10th Aug 20157:00 amRNS£1,665,000 Raised
18th Jun 20157:00 amRNSAgreement with Inflight Retail Specialist
16th Jun 20157:00 amRNSAppointment of Chief Financial Officer
1st Jun 20153:45 pmRNSResult of AGM
27th May 20157:00 amRNSDirectorate Change
12th May 20157:00 amRNSLaunch of four new Kiqplans and retail toolkits
8th May 20157:00 amRNSFinal Results
5th May 20157:01 amRNSPartnership with Tower Watson
29th Apr 20157:00 amRNSPartnership to Promote Employee-wellness
25th Feb 20157:00 amRNSAppeals Decision On Fitbit Trademark Infringement
24th Feb 20157:00 amRNSKiqplan available in Samsung's S Health globally
16th Feb 20157:00 amRNSStock Order by Leading US Midwesr Retailer
13th Feb 20157:00 amRNSTrading Update - H2 2014 Sales up 495%
29th Jan 201510:00 amRNSKiqplan Promotional Programme with Jawbone
27th Jan 20153:03 pmRNSUpdate re Legal Action Against Fitbit Inc
23rd Jan 20157:00 amRNSKiqplan: Partner of Cancer Research Race for Life
6th Jan 20157:00 amRNSAddition of New Functionality to Kiqplan
30th Dec 20147:00 amRNSTotal Voting Rights
19th Dec 20147:00 amRNSNew Contracts with Amazon, Best Buy.com and Target
9th Dec 20147:00 amRNSGBP3.5 million Placing to Accelerate Growth
26th Nov 20147:00 amRNSLoan Extension
14th Nov 20147:00 amRNSKiqplan Partner Agreement with Samsung
7th Nov 20147:00 amRNSLaunch of KiQplan
5th Nov 20144:25 pmRNSBoard Changes
5th Nov 20144:23 pmRNSDirector's Dealings
28th Oct 20142:31 pmRNSFurther Statement re: Share Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.